Caliper Posts Sharp Increase in Q3 Revenue (Thanks, Zymark!) Amid Widened Loss | GenomeWeb

NEW YORK, Nov. 6 (GenomeWeb News) - Caliper Technologies today reported a significant increase in third-quarter - largely as the result of its acquisition of Zymark this summer - atop narrowed R&D spending widened net loss.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.